The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Poliomycetes Vaccine Market Research Report 2025
Synopsis
Polio vaccines are vaccines used to prevent poliomyelitis. There are two types: one that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth.
The World Health Organization recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 37 in 2022.
The global Poliomycetes Vaccine market was valued at US$ 709.8 million in 2023 and is anticipated to reach US$ 835.1 million by 2030, witnessing a CAGR of 2.3% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Poliomycetes Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Poliomycetes Vaccine.
Report Scope
The Poliomycetes Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Poliomycetes Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Poliomycetes Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi S.A
United Pharma Industries Co Ltd
Gansu Conbest Biotech Co., Ltd.
Shenzhen Mellow Hope Pharm Industrial Co., Ltd.
China National Biotec Group
Serum Institute of India
Segment by Type
Type 1
Type 2
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Poliomycetes Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Poliomycetes Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Polio vaccines are vaccines used to prevent poliomyelitis. There are two types: one that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth.
The World Health Organization recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 37 in 2022.
The global Poliomycetes Vaccine market was valued at US$ 709.8 million in 2023 and is anticipated to reach US$ 835.1 million by 2030, witnessing a CAGR of 2.3% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Poliomycetes Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Poliomycetes Vaccine.
Report Scope
The Poliomycetes Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Poliomycetes Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Poliomycetes Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi S.A
United Pharma Industries Co Ltd
Gansu Conbest Biotech Co., Ltd.
Shenzhen Mellow Hope Pharm Industrial Co., Ltd.
China National Biotec Group
Serum Institute of India
Segment by Type
Type 1
Type 2
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Poliomycetes Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Poliomycetes Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Poliomycetes Vaccine Market Overview
1.1 Product Overview and Scope of Poliomycetes Vaccine
1.2 Poliomycetes Vaccine Segment by Type
1.2.1 Global Poliomycetes Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Type 1
1.2.3 Type 2
1.3 Poliomycetes Vaccine Segment by Application
1.3.1 Global Poliomycetes Vaccine Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Poliomycetes Vaccine Market Size Estimates and Forecasts
1.4.1 Global Poliomycetes Vaccine Revenue 2019-2030
1.4.2 Global Poliomycetes Vaccine Sales 2019-2030
1.4.3 Global Poliomycetes Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Poliomycetes Vaccine Market Competition by Manufacturers
2.1 Global Poliomycetes Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Poliomycetes Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Poliomycetes Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Poliomycetes Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Poliomycetes Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Poliomycetes Vaccine, Product Type & Application
2.7 Poliomycetes Vaccine Market Competitive Situation and Trends
2.7.1 Poliomycetes Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Poliomycetes Vaccine Players Market Share by Revenue
2.7.3 Global Poliomycetes Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Poliomycetes Vaccine Retrospective Market Scenario by Region
3.1 Global Poliomycetes Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Poliomycetes Vaccine Global Poliomycetes Vaccine Sales by Region: 2019-2030
3.2.1 Global Poliomycetes Vaccine Sales by Region: 2019-2024
3.2.2 Global Poliomycetes Vaccine Sales by Region: 2025-2030
3.3 Global Poliomycetes Vaccine Global Poliomycetes Vaccine Revenue by Region: 2019-2030
3.3.1 Global Poliomycetes Vaccine Revenue by Region: 2019-2024
3.3.2 Global Poliomycetes Vaccine Revenue by Region: 2025-2030
3.4 North America Poliomycetes Vaccine Market Facts & Figures by Country
3.4.1 North America Poliomycetes Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Poliomycetes Vaccine Sales by Country (2019-2030)
3.4.3 North America Poliomycetes Vaccine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Poliomycetes Vaccine Market Facts & Figures by Country
3.5.1 Europe Poliomycetes Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Poliomycetes Vaccine Sales by Country (2019-2030)
3.5.3 Europe Poliomycetes Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Poliomycetes Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Poliomycetes Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Poliomycetes Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Poliomycetes Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Poliomycetes Vaccine Market Facts & Figures by Country
3.7.1 Latin America Poliomycetes Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Poliomycetes Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Poliomycetes Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Poliomycetes Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Poliomycetes Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Poliomycetes Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Poliomycetes Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Poliomycetes Vaccine Sales by Type (2019-2030)
4.1.1 Global Poliomycetes Vaccine Sales by Type (2019-2024)
4.1.2 Global Poliomycetes Vaccine Sales by Type (2025-2030)
4.1.3 Global Poliomycetes Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Poliomycetes Vaccine Revenue by Type (2019-2030)
4.2.1 Global Poliomycetes Vaccine Revenue by Type (2019-2024)
4.2.2 Global Poliomycetes Vaccine Revenue by Type (2025-2030)
4.2.3 Global Poliomycetes Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Poliomycetes Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Poliomycetes Vaccine Sales by Application (2019-2030)
5.1.1 Global Poliomycetes Vaccine Sales by Application (2019-2024)
5.1.2 Global Poliomycetes Vaccine Sales by Application (2025-2030)
5.1.3 Global Poliomycetes Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Poliomycetes Vaccine Revenue by Application (2019-2030)
5.2.1 Global Poliomycetes Vaccine Revenue by Application (2019-2024)
5.2.2 Global Poliomycetes Vaccine Revenue by Application (2025-2030)
5.2.3 Global Poliomycetes Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Poliomycetes Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sanofi S.A
6.1.1 Sanofi S.A Corporation Information
6.1.2 Sanofi S.A Description and Business Overview
6.1.3 Sanofi S.A Poliomycetes Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi S.A Poliomycetes Vaccine Product Portfolio
6.1.5 Sanofi S.A Recent Developments/Updates
6.2 United Pharma Industries Co Ltd
6.2.1 United Pharma Industries Co Ltd Corporation Information
6.2.2 United Pharma Industries Co Ltd Description and Business Overview
6.2.3 United Pharma Industries Co Ltd Poliomycetes Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 United Pharma Industries Co Ltd Poliomycetes Vaccine Product Portfolio
6.2.5 United Pharma Industries Co Ltd Recent Developments/Updates
6.3 Gansu Conbest Biotech Co., Ltd.
6.3.1 Gansu Conbest Biotech Co., Ltd. Corporation Information
6.3.2 Gansu Conbest Biotech Co., Ltd. Description and Business Overview
6.3.3 Gansu Conbest Biotech Co., Ltd. Poliomycetes Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Gansu Conbest Biotech Co., Ltd. Poliomycetes Vaccine Product Portfolio
6.3.5 Gansu Conbest Biotech Co., Ltd. Recent Developments/Updates
6.4 Shenzhen Mellow Hope Pharm Industrial Co., Ltd.
6.4.1 Shenzhen Mellow Hope Pharm Industrial Co., Ltd. Corporation Information
6.4.2 Shenzhen Mellow Hope Pharm Industrial Co., Ltd. Description and Business Overview
6.4.3 Shenzhen Mellow Hope Pharm Industrial Co., Ltd. Poliomycetes Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Shenzhen Mellow Hope Pharm Industrial Co., Ltd. Poliomycetes Vaccine Product Portfolio
6.4.5 Shenzhen Mellow Hope Pharm Industrial Co., Ltd. Recent Developments/Updates
6.5 China National Biotec Group
6.5.1 China National Biotec Group Corporation Information
6.5.2 China National Biotec Group Description and Business Overview
6.5.3 China National Biotec Group Poliomycetes Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 China National Biotec Group Poliomycetes Vaccine Product Portfolio
6.5.5 China National Biotec Group Recent Developments/Updates
6.6 Serum Institute of India
6.6.1 Serum Institute of India Corporation Information
6.6.2 Serum Institute of India Description and Business Overview
6.6.3 Serum Institute of India Poliomycetes Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Serum Institute of India Poliomycetes Vaccine Product Portfolio
6.6.5 Serum Institute of India Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Poliomycetes Vaccine Industry Chain Analysis
7.2 Poliomycetes Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Poliomycetes Vaccine Production Mode & Process
7.4 Poliomycetes Vaccine Sales and Marketing
7.4.1 Poliomycetes Vaccine Sales Channels
7.4.2 Poliomycetes Vaccine Distributors
7.5 Poliomycetes Vaccine Customers
8 Poliomycetes Vaccine Market Dynamics
8.1 Poliomycetes Vaccine Industry Trends
8.2 Poliomycetes Vaccine Market Drivers
8.3 Poliomycetes Vaccine Market Challenges
8.4 Poliomycetes Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
